V116517 30-mg tablets
Sponsors
Purdue Pharma LP
Conditions
Osteoarthritis, KneePainPostherpetic Neuralgia
Phase 2
Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)
CompletedNCT01688947
Start: 2012-09-30End: 2014-04-30Updated: 2014-05-12
Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis (OA) of the Knee
CompletedNCT01688934
Start: 2012-09-30End: 2013-08-31Updated: 2013-12-05